经济效益

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （打开新窗口）

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

来源‎: Anaesthesia 2019;74(12):1534-41.

检索‎: PubMed 31448406

DOI码‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 （打开新窗口）

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. （打开新窗口）

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

来源‎: Blood Adv. 2022;6(3):785-92.

检索‎: PubMed 34781363

DOI码‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ （打开新窗口）

血液科

经济效益

中文简体（广东话）

经济效益

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （打开新窗口）

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. （打开新窗口）

联络本地医院联络委员会代表

医疗资讯汇总

影片

经济效益

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （打开新窗口）

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. （打开新窗口）

联络本地医院联络委员会代表

医疗资讯汇总

影片

选择你的语言

分享